ACQUISITIONS (Tables)

9 Months Ended

Dec. 29, 2012

Business Combinations [Abstract]

Schedule of Purchase Price Allocation

Asset class	Amounts Recognized as of December 29, 2012 (Provisional)
(in thousands)
Inventories	$	50,741
Property, plant and equipment	93,847
Intangible assets	188,500
Other assets/liabilities, net	320
Goodwill	206,303
Fair value of net assets acquired	$	539,711

Business Acquisition, Pro Forma Information

The following represents the pro forma consolidated statements of income and comprehensive income as if the acquisition of the whole blood business had been included in our consolidated results on April 3, 2011. The common stock weighted average number of shares used in calculating the pro-forma earnings per share has been retroactively adjusted for the stock split:

	Nine Months Ended
(in thousands)	December 29, 2012		December 31, 2011
Net sales	$	713,981	$	703,023
Net income	42,975		47,961
Basic earnings per share	$	0.84	$	0.94
Diluted earnings per share	$	0.82	$	0.93

The unaudited consolidated pro-forma financial information above includes the following significant adjustments made to account for certain costs which would have been incurred if the acquisition had been completed on April 3, 2011, as adjusted for the applicable tax impact. As our acquisition of the whole blood business was completed on August 1, 2012, the pro-forma adjustments for the nine months ended December 29, 2012 in the table below only include the required adjustments through August 1, 2012.

	Nine Months Ended
(in thousands)	December 29, 2012			December 31, 2011
Transaction costs (1)	$	3,184		$	—
Amortization of inventory fair value adjustment (2)	11,067			(11,067		)
Amortization of acquired intangible assets (3)	(5,712		)	(12,852		)
Interest expense incurred on acquisition financing (4)	(3,173		)	(7,137		)
Selling, general and admin expenses (5)	(3,513		)	(7,905		)